Product Overview
Portfolio AOP Health
Product overview with focus on integrated therapies for rare diseases and in critical care.
Product Overview
AOP Health's focus is on integrated therapies for rare diseases and in critical care. The portfolio comprises products in the following therapeutic areas: Hemato-oncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders and Critical Care. AOP Health’s strategic goal is to constantly deliver new treatment options with respect to rare diseases and critical care.
Hemato-Oncology
Thromboreductin®
is used to reduce an elevated blood platelet count, thrombocyte count, in patients with essential thrombocythemia.
Drug Facts
Active Ingredient
Anagrelide